Skip to content
Forodésine

Structure via PubChem · Public domain (PubChem)

EntityQ410040· pop 9· linked from 5 articles

Forodésine

Sign in to save

Also known as BCX-1777, BCX1777, Fodosine® (proposed trade name), immucillin H, immucillin-H, (2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol, Forodesine, (1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol

composé chimique

In the Vinony graph

Vinony's link graph records 5 inbound references to Forodésine, and connects out to digital object identifier, chemical formula and molar mass.

It is catalogued under topics including Chemical pages without DrugBank identifier, Drugs missing an ATC code and Drugs with no legal status.

Vinony links it to 8 Wikipedia language editions.

Chemical data

Formula
C11H14N4O4
Molecular weight
266.25 g/mol
IUPAC name
7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
SMILES
C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
InChIKey
IWKXDMQDITUYRK-KUBHLMPHSA-N
XLogP
-2.3
Polar surface area
130 Ų
H-bond donors
6
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2017
Indications
B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, leukemia, lymphoma

via ChEMBL · EBI

Wikidata facts

Mass
266.102
Show 4 more facts
chemical formula
C₁₁H₁₄N₄O₄
isomeric SMILES
C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
canonical SMILES
C1=C(C2=C(N1)C(=O)N=CN2)C3C(C(C(N3)CO)O)O
Commons category
Immucillin H
Sources (2)

via Wikidata · CC0

Article · Français

La forodésine (DCI) ou immucilline H est un composé organique de structure proche des nucléosides à base purique. C'est un médicament expérimental utilisé dans le traitement ciblé des hémopathies malignes, en particulier la leucémie lymphoblastique aiguë (LAL). Elle fait partie des inhibiteurs de la PNP. Développée par les laboratoires , elle est en 2008 en phase II des essais cliniques.

Abstract from DBpedia / Wikipedia · CC BY-SA

Available in 8 languages

via Wikidata sitelinks · CC0

Connections

Categories